RecruitingNot ApplicableNCT07606781

Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies

Analgesic Effect of Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies: A Randomized Controlled Trial


Sponsor

Tanta University

Enrollment

44 participants

Start Date

May 23, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the analgesic effect of superior hypogastric plexus block combined with transversus abdominis plane block in abdominal hysterectomies.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • Age ≥ 18 years.
  • American Society of Anesthesiology (ASA) physical status I-II.
  • Undergoing abdominal hysterectomies under general anesthesia (GA).

Exclusion Criteria8

  • History of allergies to local anesthetics.
  • Body mass index (BMI) >35 kg/m2.
  • Opioid dependency.
  • Cognitive impairment.
  • Bleeding or coagulation disorders.
  • Psychiatric and neurological disorder.
  • Local infection at the site of injection.
  • Severe heart, lung, liver, and renal dysfunction.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSuperior hypogastric plexus block + Transverse abdominis plane

Patients will receive superior hypogastric plexus block (SHPB) using 20ml of bupivacaine 0.25%+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.

OTHERSuperior hypogastric plexus block

Patients will receive superior hypogastric plexus block (SHPB) using 20ml of saline 0.9% (sham)+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07606781


Related Trials